North.cloud
Cloud spending software that helps engineering and finance teams allocate costs and automate infrastructure savings.
$60MSeries B
ParticipantG
Gaingels
Activity from announced rounds
Activity in this selectionUnited States · Oct 23, 2026 · Jan 1, 2026
Gaingels co-invests alongside venture leads in companies committed to diverse and inclusive teams, spanning seed through growth and pre-IPO rounds across technology, healthcare and consumer markets.
Its investor community includes LGBTQ+ people and allies, extending representation within the ownership of venture-backed companies. Portfolio companies work with its Gaingels Letter commitments and Venture Inclusion programme on building more inclusive organisations.
A board access programme provides free recruitment advice for diverse board members and observers. This gives founders a practical governance resource alongside a co-investment partner for a round led by another venture firm.
Sources
- Rounds participated in
- 20
- Confirmed lead rounds
- 0 12 roles undisclosed
- New companies
- 20 First participation on record · 0 follow-on
- Funding in participating rounds
- $831.4M 19 disclosed · full round size, not this investor’s share
By stage
By primary sector
6 more
Climate tech1
Cybersecurity1
Hardware1
Industrial tech1
Mobility1
Space tech1
By country
Rounds
20 in this selectionSatlyt
Software that lets satellite operators run additional applications and AI workloads on existing spacecraft.
$8MSeed
ParticipantCharter Space
Charter is a licensed insurance brokerage focused on space and defense companies, placing coverage for spacecraft, launch missions and the businesses behind them.
$5MSeed
ParticipantMoneyStack
MoneyStack provides financial counselling within behavioural-health programmes, helping people address money problems alongside treatment.
$1MUndisclosed
ParticipantMetal
An AI fundraising workspace that helps founders identify investors, research firms and manage venture rounds.
$4.5MSeed
ParticipantSuperluminal Medicines
Superluminal Medicines combines structural biology, protein dynamics, machine learning and experimental testing to discover small-molecule drugs for difficult G protein-coupled receptor targets. Its pipeline focuses on endocrine and cardiometabolic diseases, including rare genetic and hypothalamic obesity.
$60MSeries B
ParticipantMolten Salt Solutions
Lithium isotope enrichment technology for the fuel needs of advanced fission and fusion reactors.
$7MSeed
ParticipantConcordare Trials
Converts clinical trial protocol PDFs into structured digital format
UndisclosedUndisclosed
Role not disclosedStandard Metrics
AI-driven portfolio management platform for VC and private equity firms
$20MSeries B
Role not disclosedHellbender
Builds integrated edge AI perception platforms and cameras for autonomous and industrial systems
$12.5MSeed
Role not disclosedKanvas Biosciences
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
$48MSeries A
Role not disclosedLatus Bio, Inc.
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2
$97MSeries A
Role not disclosedAlloy Therapeutics
Drug discovery platforms and integrated development services for biotechnology and pharmaceutical partners.
$40MSeries E
Role not disclosedNitra
AI-native operating system for healthcare practices to automate back office functions
$187MSeries A+Series B+Debt
Role not disclosedRenoFi
Provides AI-enabled renovation financing platform for homeowners
$22MSeries B
Role not disclosedAndo
Ando develops demand forecasting and workforce scheduling tools for businesses employing hourly workers.
$4MSeed
ParticipantRapidFort
Provides continuous vulnerability remediation for software supply chain security
$42MSeries A
Role not disclosedEmobi
Emobi provides EV charging connectivity across networks.
$3.4MSeed
Role not disclosedNeurophos
Develops photonic AI inference chips for data centers
$110MSeries A
Role not disclosedCambium
Cambium develops advanced materials for defense, aerospace and other high-performance applications using AI.
$100MSeries B
Role not disclosed